相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1
XingMei Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy
Yingying Zhang et al.
JOURNAL OF DIABETES RESEARCH (2018)
PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis
Wenting Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway
Guodong Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Prevalence and Management of Diabetic Nephropathy in Western Countries
Bancha Satirapoj et al.
KIDNEY DISEASES (2015)
PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression
Ling-Li Zhang et al.
CELLULAR SIGNALLING (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Robert Ramer et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Curcumin Inhibits Transforming Growth Factor-beta 1-Induced EMT via PPAR gamma Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells
Rui Li et al.
PLOS ONE (2013)
MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer
Tommaso Colangelo et al.
NEOPLASIA (2013)
Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin-positive activated macrophages are increased in diabetic kidney
Ryo Nagase et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy
T. Zhou et al.
DIABETOLOGIA (2012)
Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice
T. Kuwabara et al.
DIABETOLOGIA (2012)
Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade
Hiroshi Kusunoki et al.
HYPERTENSION (2012)
Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects
Furu Wang et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2012)
β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells
Wei Zhang et al.
PEPTIDES (2012)
Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells
W. M. Wang et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Epithelial-mesenchymal transition in renal fibrosis - evidence for and against
Maria Fragiadaki et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats
Victor P. Bilan et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation
Ying Yao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis
Yasuhiko Kanaguchi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Rosiglitazone Inhibits Transforming Growth Factor-β1 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells
Yawei Liu et al.
PLOS ONE (2011)
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions
Wawaimuli Arozal et al.
TOXICOLOGY (2011)
Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)
Hoda E. Mohamad et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
The Glomerular Podocyte as a Target of Growth Hormone Action: Implications for the Pathogenesis of Diabetic Nephropathy
P. Anil Kumar et al.
CURRENT DIABETES REVIEWS (2011)
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Benjamin D. Humphreys et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Unique biochemical properties of the protein tyrosine phosphatase activity of PTEN-Demonstration of different active site structural requirements for phosphopeptide and phospholipid phosphatase activities of PTEN
Joel Yeong-Chit Chia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
Charlotte Ling et al.
DIABETES (2009)
Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol
Furong Wang et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells
Liang-qi Cao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Rosiglitazone suppresses human lung carcinoma cell growth through PPAR-γ-dependent and PPARγ-independent signal pathways
SW Han et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Estrogen receptor α binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor γ signaling in breast cancer cells
D Bonofiglio et al.
CLINICAL CANCER RESEARCH (2005)
Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPAR-γ co-activator, PGC-I, in human breast cancer correlates with clinical outcomes
WG Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Membrane-binding and activation mechanism of PTEN
S Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Generation and functional confirmation of a conditional null PPARγ allele in mice
JR Jones et al.
GENESIS (2002)
Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN
L Patel et al.
CURRENT BIOLOGY (2001)
分享论文
